The Graded Prognostic Assessment (GPA) is a tool to help predict survival of patients with brain mets and it’s now here for small cell lung cancer as well as for non-small cell lung cancer with PD-L1 expression, available as an online tool of course. | Sperduto, Int J Radiat Oncol Biol Phys 2022
